Both special issues BChallenges and Controversies in Translational Stroke Research, Part 1 and 2^provide an excellent overview of the methodological challenges encountered in the various stages of planning, implementation, and evaluation of preclinical stroke studies. The topics discussed do not apply solely to the field of stroke research, but to many other fields of translational science as well. This collection of articles by highly informed scientists clearly illustrates that a multitude of approaches and measures is needed to address bias in preclinical research in order to increase the translation of knowledge from basic science to clinical practice.
Over the past decade, preclinical researchers have learned just how prone to bias each stage of their experimental work is. Due to increased awareness of widespread methodological bias and obvious translational roadblocks in stroke research, checklists and guidelines have been developed to support basic researchers in the design, execution, analysis, interpretation, and reporting of animal experiments. Not only have guidelines been published to improve the general design and reporting of preclinical animal studies, the methodology of translational research as such has also been questioned. Novel approaches have been proposed to minimize bias and improve translational success. These strategies range from engaging multiple laboratories in preclinical trials [1] , to increasing awareness of the importance of sex, age, and strain-related differences [2, 3] , recognizing biological and methodological variances [4] , the impact of diseasespecific comorbidities [5] and anesthetics [6] on measured endpoints, and using proper outcome modalities [7] [8] [9] in experimental stroke research.
One of the main goals of introducing guidelines for designing, executing, and reporting of in vivo animal experiments was to enable better systematic reviews and meta-analyses of preclinical study publications. Highquality systematic reviews of animal experiments will most likely improve scientific quality, as well as decision-making on whether or not to start a clinical trial in the first place. Although rigor in implementation of standards in animal studies is probably the best way to achieve reproducible results-and facilitate systematic reviews and meta-analysis-one must keep in mind that experiments conducted under highly standardized conditions may represent a driver of poor reproducibility (producing results with little external validity) [10] .
Multilaboratory studies would likely contribute to the heterogenization of experimental conditions, presumably increase external validity and, as a result, the predictive value of preclinical research. Community-based feedback regarding multicenter preclinical randomized trials indicated a high level of acceptance for the currently defined potential frameworks and guidelines [1] . However, the survey also revealed that there is room for improvement in quality assurance. One third of participants, for example, did not see a need for blinding and/or randomization, and less than half of researchers considered arterial blood gases/pH monitoring, or investigating at least two species (STAIR recommendations) to be necessary [1] . This is an important finding and corroborates concerns that implementing frameworks and guidelines proposed by selected experts and renowned individuals can be challenging within the research community base. Reporting guidelines (e.g., ARRIVE), which represent a cornerstone of efforts to reduce bias in animal research, are largely ignored [11] . Less than half of authors publishing in journals which conform to guidelines have even heard of them [12] . It is therefore of utmost importance to raise awareness of tools available to improve planning, reporting, and analyzing preclinical stroke research (Table 1) 
In addition to stepping up efforts to rigorously implement existing tools in order to reduce risks of bias and advance the quality of animal studies, further research is needed to improve the construct validity of animal models and to understand underlying causes of poor external validity [12] . However, any measure is only as good as its acceptance by the broad research community. Educating young researchers in good RIGOR [17] Recommendations and guidelines to improve the quality of preclinical research through rigorous study design and transparent reporting data from experimental studies.
(http://www.ninds.nih.gov/funding/transparency_in_reporting_guidance.pdf) EDA [18] Experimental Design Assistant. Software designed to support researchers in the planning of animal experiments, ensuring robust study design, and reliable and reproducible findings.
(https://eda.nc3rs.org.uk/) DEPART [19] Design and Execution of Protocols for Animal Research and Treatment. A checklist to consult prior to starting experiments. Includes considerations that should be made during the design and execution of animal experiments. ARRIVE [20] Animal Research: Reporting of In Vivo Experiments. Developed as part of an NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research) initiative to improve the design, analysis, and reporting of research using animals. More commonly used than the GSPC guidelines. (https://www.nc3rs.org. uk/arrive-guidelines) GSPC [21] Gold Standard Publication Checklist. Initiative to optimize the design and execution of new animal experiments and to increase the quality of reporting of completed animal studies. Some overlap with the ARRIVE guidelines but certain items (housing conditions, nutrition) are given in greater detail. More focused on the planning, design, and execution of animal experiments rather than its reporting. CAMARADES Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies. Developed for evaluating candidate stroke drugs. This platform provides a support framework for groups involved in the systematic review and meta-analysis of data from experimental animal studies in general. It aims to act as a central hub for data sharing and act as repository for completed reviews. laboratory practices, encouraging respect for their wide applicability (in small research laboratories with fewer personnel and financial resources), as well as the suitability of suggested measures for daily use will probably play a crucial role in the battle to overcome translational roadblocks.
